Fluid secretion assays such as steady-state lumen area (SLA) and rectal organoid morphology analysis (ROMA) measurements allow for the quantification of CFTR function at levels that differentiate between healthy- and CF-intestinal organoids [25,26]. This evidence concerns the gene CFTR and cystic fibrosis.